News | May 05, 2025
Ami Organics Q4 FY25 PAT up at Rs. 62.48 Cr
The company has posted net profit of Rs. 158.71 crores for the Financial Year ended March 31, 2025
The company has posted net profit of Rs. 158.71 crores for the Financial Year ended March 31, 2025
Ami Organics’ Ankleshwar Unit II gets GMP compliant by PMDA Japan
This change is subject to the approval of the shareholders of the company, the Ministry of Corporate Affairs and other statutory and regulatory authorities,
Ami informs that PMDA Japan has issued Inspection Result Report declaring the Sachin facility as a Good Manufacturing Practices (GMP) compliant.
The grant is designated for the research and development of Pyronaridine
This development will position the company at the forefront of anti- malaria API production globally and is expected to drive substantial growth and profitability
Q1FY25 Revenue from Operations grew by 15% to Rs. 177 crore
The Issue opened on June 18, 2024 and closed on June 21, 2024
Sapala has a strong customer base including innovator Pharma, CDMOs & diagnostic companies
Dr. Reddy's Laboratories gets Form 483 from USFDA with 4 observations for API facility
Subscribe To Our Newsletter & Stay Updated
